Aquarius Surgical Technologies Inc. Stock

Equities

ASTI

CA03842P1009

Advanced Medical Equipment & Technology

Market Closed - Canadian Securities Exchange 11:41:48 2024-06-03 am EDT 5-day change 1st Jan Change
0.02 CAD 0.00% Intraday chart for Aquarius Surgical Technologies Inc. 0.00% +100.00%
Sales 2022 328K 238K Sales 2023 204K 148K Capitalization 276K 200K
Net income 2022 - 0 Net income 2023 - 0 EV / Sales 2022 14.5 x
Net Debt 2022 3.08M 2.24M Net Debt 2023 3.39M 2.46M EV / Sales 2023 18 x
P/E ratio 2022
-1.93 x
P/E ratio 2023
-0.38 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Aquarius Surgical Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Aquarius Surgical Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Aquarius Surgical Technologies Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Aquarius Surgical Technologies Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Aquarius Surgical Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Aquarius Surgical Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Aquarius Surgical Technologies Inc. Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Aquarius Surgical Technologies Inc. Auditor Raises 'Going Concern' Doubt CI
Aquarius Surgical Technologies Inc. Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Aquarius Surgical Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Aquarius Surgical Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Aquarius Surgical Technologies Inc. Reports Earnings Results for the Full Year Ended March 31, 2021 CI
Aquarius Surgical Technologies Inc. Announces Resignation of Gordon Willox as Director CI
Aquarius Surgical Technologies Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2020 CI
Aquarius Surgical Technologies Inc. Reports Earnings Results for the Second Quarter Ended September 30, 2020 CI
More news
1 month-50.00%
3 months-42.86%
6 months+100.00%
Current year+100.00%
More quotes
1 week
0.02
Extreme 0.02
0.02
1 month
0.02
Extreme 0.02
0.04
Current year
0.01
Extreme 0.005
0.05
1 year
0.01
Extreme 0.005
0.05
3 years
0.01
Extreme 0.005
0.20
5 years
0.00
Extreme 0
0.65
10 years
0.00
Extreme 0
1.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chairman 84 91-12-31
Members of the board TitleAgeSince
Chairman 84 91-12-31
Director/Board Member - 15-12-31
Director/Board Member 64 -
More insiders
Date Price Change Volume
24-06-03 0.02 0.00% 9,500
24-05-31 0.02 0.00% 51,500

Delayed Quote Canadian Securities Exchange, June 03, 2024 at 11:41 am EDT

More quotes
Aquarius Surgical Technologies Inc. is a Canada-based provider of minimally invasive medical laser systems and consumables for multiple medical disciplines, principally in the field of urology. Its solutions also include clinical education, service, support and maintenance. The Company is primary focused on the development, sale, distribution, marketing and exploitation of technologies for use in surgical environments. It is involved in lasers and fibers sales and service operations through its subsidiary Surgical Lasers Inc. (SLI). SLI is an international distributor, service, support and training organization providing integrated laser-based solutions across multiple medical disciplines. These disciplines include urology, gynecology, ophthalmology, thoracic, ear nose throat (ENT), cardiovascular, and neurosurgery, many of which are now considered the standard of care for treatment.
More about the company